NIPH
AMED

NN Investment Partners Holdings’s Amedisys AMED Stock Holding History

NN Investment Partners Holdings’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,095
Closed -$1.47M – 798
2021
Q4 		$1.47M Buy
9,095
+866
+11% +$139K 0.01% 597
2021
Q3 		$1.23M Buy
8,229
+984
+14% +$205K 0.01% 618
2021
Q2 		$1.77M Buy
7,245
+500
+7% +$131K 0.01% 566
2021
Q1 		$1.79M Hold
6,745
– – 0.01% 546
2020
Q4 		$1.98M Sell
6,745
-1,674
-20% -$429K 0.01% 520
2020
Q3 		$1.99M Sell
8,419
-1,304
-13% -$296K 0.01% 490
2020
Q2 		$1.93M Buy
9,723
+700
+8% +$131K 0.01% 500
2020
Q1 		$1.66M Sell
9,023
-4,100
-31% -$729K 0.01% 488
2019
Q4 		$2.19M Sell
13,123
-7,000
-35% -$1.04M 0.01% 484
2019
Q3 		$2.64M Sell
20,123
-9,986
-33% -$1.3M 0.02% 433
2019
Q2 		$3.65M Sell
30,109
-2,422
-7% -$287K 0.03% 379
2019
Q1 		$4.01M Buy
32,531
+23,255
+251% +$2.92M 0.03% 370
2018
Q4 		$1.09M Buy
+9,276
New +$1.09M 0.01% 536

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

NN Investment Partners Holdings's AMED Position: Q1 2022 in Review

NN Investment Partners Holdings sold out of Amedisys (AMED) in Q1 2022, closing a stake of 9,095 shares — an estimated $1.47M sold.

NN Investment Partners Holdings first reported a position in AMED in Q4 2018 and held it in 13 quarters. The position peaked at $4.01M in Q1 2019. 329 funds tracked by Wall St. Rank hold AMED as of Q1 2022.

  • NN Investment Partners Holdings reported no remaining Amedisys position as of Q1 2022 after selling out during the quarter.
  • NN Investment Partners Holdings sold 9,095 Amedisys shares in Q1 2022, an estimated $1.47M.
  • NN Investment Partners Holdings first reported a position in Amedisys in Q4 2018 and held it in 13 quarters.
  • NN Investment Partners Holdings's Amedisys position peaked at $4.01M in Q1 2019.
  • 329 funds tracked by Wall St. Rank held Amedisys as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.